# ClinicalTrials.gov record NCT02559206

> PeptideScanner retained ClinicalTrials.gov record NCT02559206 at 2026-07-30T20:29:13.579Z. Its registry update date was 2020-04-24, and PeptideScanner's reviewed identity mapping was linaclotide.

- Evidence object: `story:clinicaltrials-gov-nct02559206-linaclotide:v1`
- Evidence domain: Clinical trials
- Date in source: 2020-04-24
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct02559206-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02559206-linaclotide-v1.json
- Content SHA-256: `e9f58d65c9603f28b93d22a8dc37d2304d7ff7e9e184af9e36ea8ea426bfaaa3`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT02559206 ([`ctg-observation-nct02559206-2020-04-24-5db39d62c302`](#source-ctg-observation-nct02559206-2020-04-24-5db39d62c302))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT02559206 at 2026-07-30T20:29:13.579Z. Its registry update date was 2020-04-24, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct02559206-2020-04-24-5db39d62c302`](#source-ctg-observation-nct02559206-2020-04-24-5db39d62c302))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT02559206 at 2026-07-30T20:29:13.579Z. Its registry update date was 2020-04-24, and PeptideScanner's reviewed identity mapping was linaclotide. ([`ctg-observation-nct02559206-2020-04-24-5db39d62c302`](#source-ctg-observation-nct02559206-2020-04-24-5db39d62c302))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct02559206-2020-04-24-5db39d62c302`](#source-ctg-observation-nct02559206-2020-04-24-5db39d62c302))

## Sources

<a id="source-ctg-observation-nct02559206-2020-04-24-5db39d62c302"></a>
- **ClinicalTrials.gov record NCT02559206 · retained source version 2020-04-24:5db39d62c30216da474d709d107253525c3813edbca2b746a77f876201b195da** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT02559206) (`ctg-observation-nct02559206-2020-04-24-5db39d62c302`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT02559206." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct02559206-linaclotide-v1.json SHA-256: e9f58d65c9603f28b93d22a8dc37d2304d7ff7e9e184af9e36ea8ea426bfaaa3.